Morgan Stanley upgrades Freeport-McMoRan stock to Overweight despite price target cut

Morgan Stanley upgraded Freeport-McMoRan (FCX) to Overweight with a $48 price target, citing an excessive recent stock reaction and the company's continued benefits from elevated gold prices and domestic U.S. tariffs. This upgrade follows FCX's strong Q2 2025 financial results, which significantly beat analyst expectations for both EPS and revenue. While the company faces new 50% U.S. tariffs on certain copper imports and BMO Capital recently lowered its price target due to a reduced gold production outlook, other analysts maintain positive ratings, highlighting the mixed operational environment.

Analysis

Freeport-McMoRan (FCX) presents a complex investment case marked by a bullish analyst upgrade set against a backdrop of regulatory and operational uncertainty. Morgan Stanley has upgraded the stock to Overweight, positing that the market's recent negative reaction was excessive. This view is supported by FCX's strong second-quarter 2025 financial performance, where earnings per share of $0.54 beat consensus by 20% and revenue of $7.58 billion surpassed expectations. Further tailwinds include elevated gold prices, which are lowering the company's unit net cash costs, and the benefit from existing 50% tariffs on a majority of its U.S. volumes. However, significant headwinds temper this positive outlook. A newly announced 50% tariff on key copper imports, set to take effect August 1, introduces a new operational challenge. Furthermore, both Morgan Stanley and BMO Capital have lowered their price targets—to $48 and $54, respectively—with BMO citing a reduced 2025 gold production target. This combination of strong current results and analyst support, contrasted with forward-looking risks from trade policy and production guidance, justifies the mixed sentiment and suggests the stock is currently balanced between clear catalysts and tangible risks.

Key Decisions for Investors

• The Morgan Stanley upgrade to Overweight, coupled with a significant Q2 earnings beat, presents a potential catalyst for investors, particularly as the bank views the recent share price weakness as an overreaction.
• Investors must closely monitor the impact of the newly imposed 50% copper import tariff and any further downward revisions to gold production targets, as these represent the primary risks that have prompted price target reductions from multiple analysts.
• Given that the stock trades near its fair value estimate amidst conflicting signals, investors should weigh whether the potential 20% upside to Morgan Stanley's $48 target adequately compensates for the heightened risks from trade policy and potential production misses.